PDMR dealing
Download the full announcement
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-traded medical diagnostics business, announces that on 19 December 2018, the Company was notified by Mike Salter (President, Americas) that he has today purchased 125,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").
EKF Diagnostics Holdings plc |
www.ekfdiagnostics.com Tel: 00 44 29 2071 0570 |
N+1 Singer (Nomad & Broker)
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance) |
Tel: 020 7496 3000 |
Walbrook PR Limited |
Tel: 020 7933 8780 or Mob: 07980 541 893 / 07584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
Name |
Mike Salter |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
President, Americas |
||||
b) |
Initial notification /Amendment |
Initial Notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
EKF Diagnostics Holdings plc |
||||
b) |
LEI |
213800DXTF3EAUK1AR05 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1p each (“Ordinary Shares”)
ISIN Code: GB0031509804 |
||||
b) |
Nature of the transaction |
Purchase of shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information - Aggregated volume - Price |
n/a |
||||
e) |
Date of the transaction |
19 December 2018 |
||||
f) |
Place of the transaction |
London Stock Exchange |
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.